Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.87 USD | +1.21% | -3.32% | +17.88% |
May. 28 | Keros Therapeutics, Inc. Appoints Jean-Jacques Bienaimé to Its Board of Directors, Effective June 1, 2024 | CI |
May. 08 | Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.88% | 1.69B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q3 Revenue $8,000